UAB Neurology study adds to evidence that massive, second-wave reaction kills nerve cells.
The finding may help to avert more of the bleeds and blood clots that come when a patient’s starting dose misses the drug’s narrow safety window.
Work may provide insight into drug design for autism, movement disorders.
Investigators studying a long-acting injectable formulation of aripiprazole, a partial dopamine agonist.
UAB and the Birmingham VA Medical Center join forces for research to improve Veterans' health care.
Success of ACE inhibitors, alpha blockers, calcium channel blockers and diuretics same in women and men; diuretic reduces cardiovascular complications.
Investigators in the study received a a $1.125 million grant from the National Eye Institute, one of the National Institutes of Health.
Rosyln Mannon, M.D., director of research at the UAB Comprehensive Transplant Institute and a kidney transplant specialist, talks with The Mix.
While most posts from The Mix feature a science story, we have also begun regularly sharing images coming out of UAB research.